ESC 365 - Cardiac reverse remodeling after SGLT2 inhibitor therapy: exploring beyond sex differences

Open Access

Cardiac reverse remodeling after SGLT2 inhibitor therapy: exploring beyond sex differences

Session: Cardiac remodeling across the ejection fraction spectrum

Topic: Ventricular Remodelling

Speaker: Doctor S. Prosperi (Rome, IT)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Doctor Silvia Prosperi

Sapienza University of Rome, Rome (Italy)

1 presentation

0 follower

4 more presentations in this session

EPA:DHA 6:1 prevents right ventricular dysfunction and lung vascular remodeling in monocrotaline-induced pulmonary arterial hypertension in rats by mitigating inflammatory and pro-oxidant responses

Speaker: Doctor S. AMISSI (Strasbourg, FR)

Left ventricular reverse remodeling in heart failure with reduced ejection fraction: determinants and outcomes in a multidisciplinary heart failure clinic in a resource limited setting

Speaker: Doctor B. Chung (Kuching, MY)

Echocardiographic parameters in patients with right heart failure and sarcopenia.

Speaker: Doctor M. Hernandez Hernandez (Mexico City, MX)

Multiparametric approach to predict long-term survival in ischemic heart failure patients undergoing surgical ventricular reconstruction

Speaker: Doctor G. Guida (San Donato Milanese, IT)

Access the full session

Cardiac remodeling across the ejection fraction spectrum

Speakers: Doctor S. Prosperi, Doctor S. AMISSI, Doctor B. Chung, Doctor M. Hernandez Hernandez, Doctor G. Guida

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources